Associations of chronic kidney disease markers with cognitive function: a 12-year follow-up study

Manuscript Number: 

18-0498R1

Author(s): 
Kaarin J. Anstey, Steven J. Chadban, Dianna J. Magliano, Kevan R. Polkinghorne, Julian W. Sacre, Jonathan E. Shaw, Paul Z. Zimmet

Disclosures

Kaarin J. Anstey

  • Nothing to Disclose

Steven J. Chadban

  • Nothing to Disclose

Dianna J. Magliano

  • Nothing to Disclose

Kevan R. Polkinghorne

  • Nothing to Disclose

Julian W. Sacre

  • Nothing to Disclose

Jonathan E. Shaw

  • Consulting Fees:
    I have been a paid member of scientific advisory boards for the following pharmaceutical companies: Astra Zeneca; Sanofi; Novo Nordisk; MSD; Eli Lilly; Abbott
    Lecture Fees:
    I have received lecture fees from the following pharmaceutical companies: Mylan, Astra Zeneca; Sanofi; Boehringer Ingelheim
    Grants
    • Agency: 
      Astra Zeneca
      Dates: 
      2015-2018

Paul Z. Zimmet

  • Nothing to Disclose